Morgan Stanley Private Equity Asia
MSPEA backs India NBFC Five Star
Morgan Stanley Private Equity Asia (MSPEA) has invested INR1.14 billion ($16.9 million) in Five Star Business Finance, an India-based non-banking finance company (NBFC) that specializes in small ticket business and housing loans.
PE investors see value in forward planning on operational improvement
Operational strategies should be defined in detail well before any financial commitment is made, according to industry participants at the Hong Kong Venture Capital & Private Equity Association's (HKVCA) China summit.
MSPEA nets 4.5x return on part-exit from Hong Kong's AMTD
Morgan Stanley Private Equity Asia (MSPEA) secured a 4.5x return on its partial exit from Hong Kong-based financial advisor AMTD when China Minsheng International and LR Capital Group took a majority interest in the business.
China hospitals: Long-term cure?
Hospitals have emerged as a phenomenally popular target for private equity in China, but it may take time for ambitious growth projections to be realized
Taiwan's Fair Trade Commission approves CNS sale
Taiwan’s Fair Trade Commission has approved the acquisition of cable television provider China Network Systems (CNS) by Morgan Stanley Private Equity Asia (MSPEA) and Far EasTone Telecommunications.
CreditEase's Yirendai targets up to $82.5m in US IPO
Yirendai, an online peer-to-peer (P2P) online platform owned by China-based micro-credit loan player CreditEase, is looking to raise up to $82.5 million through its US IPO.
MSPEA exits Sino Gas stake to investment partner
Morgan Stanley Private Equity Asia (MSPEA) has agreed to sell its 38.7% stake in Sino Gas to Zhongyu Gas. The buyer participated alongside MSPEA in the privatization of Sino Gas last year and will now take a majority stake in the business.
Taiwan must think globally, overcome China issues - AVCJ Forum
Taiwan needs to think globally as it looks for ways that domestic companies can leverage growth in other markets, but this means addressing mainland Chinese involvement in the economy.
CreditEase's online P2P lending unit files for US IPO
Yirendai.com, an online peer-to-peer (P2P) online platform owned by China-based micro-credit loan player CreditEase, has filed for an IPO in the US.
Asian GPs should share the wealth internally - AVCJ Forum
The Asian private equity talent pool is deepening but GPs must ensure their compensation schemes are well balanced in order to retain mid-level staff, industry participants told the AVCJ Forum.
Korea middle market: Behind the curtain
Korea’s middle market continues to blossom thanks to succession issues, restructuring and ambitions to expand overseas. But deals are struck in strict confidence – and GPs say that is how it should remain
Korea buyouts: Who's selling?
Thanks to a steady stream of large cap deals, Korea accounts for a growing share of Asia buyout activity. But can this trend be sustained?
Portfolio: Morgan Stanley Private Equity Asia and AMTD
Hong Kong-based financial advisor AMTD wants to meet the needs of mainland investors looking to access international markets. Morgan Stanley Private Equity Asia is helping the firm best position itself
Deal focus: CNS promises PE watershed in Taiwan
Most PE investors have secured profitable exits from Taiwan’s cable television industry. Now MBK Partners has joined the club, although like some of the others, the path to liquidity has not been smooth.
MSPEA, Far EasTone to buy Taiwan's CNS from MBK
Morgan Stanley Private Equity Asia (MSPEA) and Far EasTone Telecommunications have agreed to buy Taiwan-based cable television provider China Network Systems (CNS) from MBK Partners.
China hospitals: Complicated prescription
Private equity investors see huge opportunities in China’s hospital space on the back of healthcare reforms. But valuations are high, doctors are in limited supply, and regulation can be a headache
MSPEA enters the China hospital space
To Homer Sun, CIO at Morgan Stanley Private Equity Asia (MSPEA), the current climate in China’s hospital services space is reminiscent of pharmaceuticals circa 2008. Government policy was pushing the industry towards consolidation and MSPEA capitalized,...
MSPEA, Sihuan Pharma invest in Chinese hospitals - UPDATE
Morgan Stanley Private Equity Asia (MSPEA) has teamed up with Sihuan Pharmaceuticals – one of its portfolio companies – and that company’s chairman to invest RMB1.24 billion ($200 million) in two Chinese hospitals.
Being global is about being good, not big - AVCJ Forum
The priority when building a global company is creating quality, not necessarily expanding outside your local market, industry participants told the AVCJ Forum.
Morgan Stanley PE Asia backs Hong Kong financial advisor AMTD
Morgan Stanley Private Equity Asia (MSPEA) has invested an undisclosed sum in AMTD, Hong Kong’s leading independent financial planner (IFA) and insurance broker.
MSPEA-backed Tianhe drops on resumption of trading
Morgan Stanley Private Equity Asia (MSPEA) portfolio company Tianhe Chemicals saw its stock drop 43% on resumption of trading in Hong Kong following allegations of fraud. Tianhe issued a lengthy rebuttal of the allegations, while simultaneously announcing...
China short-selling: Short shrift?
“The chairman just threatened to have me killed.” Delivered in a panicked voice, the statement brought proceedings to a standstill. As it happened, the meeting had been convened to share the news of my imminent departure with staff. But my bombshell...
Tianhe denies fraud allegations, MSPEA offers full support
Tianhe Chemicals has issued a point-by-point rebuttal of allegations that it made false statements in its IPO prospectus, with second-largest investor Morgan Stanley Private Equity Asia (MSPEA) declaring its full support.
Q&A: Morgan Stanley PE Asia's Michael Chung
Michael Chung, Seoul-based managing director with Morgan Stanley Private Equity Asia (MSPEA), discusses the intricacies of buying businesses from local conglomerates – and the prospects for exits via trade sales and IPOs.